- Home
- CTSH vs BNTX Comparison
CTSH vs BNTX Comparison
Compare CTSH & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSH
- BNTX
- Stock Information
- Founded
- CTSH 1994
- BNTX 2008
- Country
- CTSH United States
- BNTX Germany
- Employees
- CTSH N/A
- BNTX 6133
- Industry
- CTSH EDP Services
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CTSH Technology
- BNTX Health Care
- Exchange
- CTSH Nasdaq
- BNTX Nasdaq
- Market Cap
- CTSH 35.6B
- BNTX 29.2B
- IPO Year
- CTSH 1998
- BNTX 2019
- Fundamental
- Price
- CTSH $77.14
- BNTX $122.68
- Analyst Decision
- CTSH Hold
- BNTX Buy
- Analyst Count
- CTSH 20
- BNTX 14
- Target Price
- CTSH $77.89
- BNTX $126.00
- AVG Volume (30 Days)
- CTSH 2.9M
- BNTX 1.7M
- Earning Date
- CTSH 10-30-2024
- BNTX 11-04-2024
- Dividend Yield
- CTSH 1.56%
- BNTX N/A
- EPS Growth
- CTSH 2.54
- BNTX N/A
- EPS
- CTSH 4.39
- BNTX N/A
- Revenue
- CTSH $19,265,000,000.00
- BNTX $2,882,888,674.00
- Revenue This Year
- CTSH $3.26
- BNTX N/A
- Revenue Next Year
- CTSH $5.74
- BNTX $0.73
- P/E Ratio
- CTSH $17.59
- BNTX N/A
- Revenue Growth
- CTSH N/A
- BNTX N/A
- 52 Week Low
- CTSH $62.14
- BNTX $76.53
- 52 Week High
- CTSH $80.27
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- CTSH 55.55
- BNTX 70.96
- Support Level
- CTSH $75.61
- BNTX $115.16
- Resistance Level
- CTSH $77.40
- BNTX $120.76
- Average True Range (ATR)
- CTSH 1.14
- BNTX 4.42
- MACD
- CTSH -0.00
- BNTX -0.28
- Stochastic Oscillator
- CTSH 67.53
- BNTX 58.35
About CTSH Cognizant Technology Solutions Corporation
Cognizant is a global IT services provider, offering consulting and outsourcing services to some of the world's largest enterprises spanning the financial services, media and communications, healthcare, natural resources, and consumer products industries. Cognizant employs nearly 300,000 people globally, roughly 70% of whom are in India, although the company's headquarters are in Teaneck, New Jersey.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.